COMMUNIQUÉS West-GlobeNewswire

Evogene Financial Results for the Fourth Quarter and Full Year 2017 Earnings Announcement Schedule
12/02/2018
REHOVOT, Israel, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN )(TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique computational [...]
Codexis to Present at the 25th International Molecular Medicine Tri-Conference
12/02/2018
REDWOOD CITY, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the development of an improved [...]
Ziopharm Oncology Presents Data on Very Rapid Production of CAR T Cells at Keystone Symposia Emerging Cellular Therapies: T Cells and Beyond
12/02/2018
BOSTON, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP ), a biotechnology company focused on development of next generation immunotherapies utilizing gene- and cell-based therapies to treat [...]
ChromaDex Corporation Reports Preliminary 2017 Results
12/02/2018
IRVINE, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age, is providing [...]
ContraVir Pharmaceuticals Reaches Agreement with the FDA on the NDA Package for TXL™ Leveraging the 505(b)(2) Regulatory Pathway
12/02/2018
EDISON, N.J., Feb. 12, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
Genetic Technologies Limited: Update on Strategic Alliance
12/02/2018
MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”, “GTG”), wishes to advise that the Company is presently in discussions with the ASX regarding the [...]
Herantis Pharma strengthens team - Outi Lahdenperä and Antti Vuolanto have joined Herantis
12/02/2018
Herantis Pharma strengthens team - Outi Lahdenperä and Antti Vuolanto have joined Herantis Herantis Pharma Plc Press release 12 Feb 2018 at 9:00 am Herantis Pharma plc ("Herantis") has strengthened its core team with [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
12/02/2018
REGULATED INFORMATION GHENT, Belgium, 12 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
12/02/2018
REGULATED INFORMATION GHENT, Belgium, 12 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Adamas Announces New Employment Inducement Grant
09/02/2018
EMERYVILLE, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the compensation committee of the company’s board of directors granted five new employees the [...]
Aurora Spine Completes Private Placement
09/02/2018
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. CARLSBAD, Calif., Feb. 09, 2018 (GLOBE [...]
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017
09/02/2018
NORTHVALE, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products [...]
Cytori Therapeutics Announces Inducement Grants for New Employees
09/02/2018
SAN DIEGO, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX ) (the “Company”), announced today that the Compensation Committee of the Company's Board of Directors granted non-qualified stock [...]
AFA: Increased Spending at the NIH Paves the Way for a Much-Needed Boost to Funding for Alzheimer’s Research
09/02/2018
NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Congressional leaders have agreed to a two-year budget package that calls for increasing spending at the National Institutes of Health (NIH) by $2 billion. This provides the [...]
HealthEquity’s Jon Soldan Named to Utah Business’ Forty Under 40
09/02/2018
DRAPER, Utah, Feb. 09, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ), a leading health savings account (HSA) provider, is pleased to announce that its Executive Vice President of Operations, Jon Soldan, has [...]
RavenQuest Acquires Remaining Shares Under Alberta Green Biotech Acquisition
09/02/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, Feb. [...]
BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Patients with Urothelial Carcinoma at 2018 Genitourinary Cancers Symposium
09/02/2018
CAMBRIDGE, Mass., and BEIJING, China, Feb. 09, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
Aviragen Adjourns Special Meeting of Stockholders to Allow Stockholders to Consider Improved Merger Deal Terms
09/02/2018
CAS Group Supports Improved Deal Company Currently has Sufficient Votes to Approve Merger ATLANTA, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ: AVIR ) today announced that the reconvened [...]
INSYS Therapeutics Addresses Maryland Attorney General’s Motion
09/02/2018
PHOENIX, Feb. 09, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released the [...]

Pages